Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W H SUMMERSKILL

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Mayo Clinic Proceedings|May 1, 1976
Alpha1-antitrypsin phenotypes in chronic active liver disease and primary biliary cirrhosisF Kueppers, E R Dickson, W H Summerskill
Clinical Pharmacokinetics|September 1, 1982
Comparative serum prednisone and prednisolone concentrations following administration to patients with chronic active liver diseaseM Uribe, W H Summerskill, V L Go
Gastroenterology|May 1, 1976
Abnormalities of chemical tests for copper metabolism in chronic active liver disease: differentiation from Wilson's diseaseN F LaRusso, W H Summerskill, J T McCall
Gastroenterology|May 1, 1977
Prednisone for chronic active liver disease: pharmacokinetics, including conversion to prednisoloneS W Schalm, W H Summerskill, V L Go
Digestive Diseases and Sciences|February 1, 1979
Different gastric, pancreatic, and biliary responses to solid-liquid or homogenized mealsJ R Malagelada, V L Go, W H Summerskill
Gastroenterology|September 1, 1976
Responses to treatment can differentiate chronic active liver disease with cholangitic features from the primary biliary cirrhosis syndromeA P Geubel, A H Baggenstoss, W H Summerskill
Gastroenterology|October 1, 1979
Development and early prognosis of esophageal varices in severe chronic active liver disease (CALD) treated with prednisoneA J Czaja, A M Wolf, W H Summerskill
The Journal of Clinical Investigation|August 1, 1970
Pancreozymin bioassay in man based on pancreatic enzyme secretion: potency of specific amino acids and other digestive productsV L Go, A F Hofmann, W H Summerskill
Annals of Clinical Research|June 1, 1976
Failure of customary treatment in chronic active liver disease: causes and managementS W Schalm, H V Ammon, W H Summerskill
Mayo Clinic Proceedings|December 1, 1976
Development of radioimmunoassays for prednisone and prednisolone. Application to studies of hepatic metabolism of prednisoneS W Schalm, W H Summerskill, V L Go
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Mayo Clinic Proceedings|May 1, 1976
Alpha1-antitrypsin phenotypes in chronic active liver disease and primary biliary cirrhosisF Kueppers, E R Dickson, W H Summerskill
Clinical Pharmacokinetics|September 1, 1982
Comparative serum prednisone and prednisolone concentrations following administration to patients with chronic active liver diseaseM Uribe, W H Summerskill, V L Go
Gastroenterology|May 1, 1976
Abnormalities of chemical tests for copper metabolism in chronic active liver disease: differentiation from Wilson's diseaseN F LaRusso, W H Summerskill, J T McCall
Gastroenterology|May 1, 1977
Prednisone for chronic active liver disease: pharmacokinetics, including conversion to prednisoloneS W Schalm, W H Summerskill, V L Go
Digestive Diseases and Sciences|February 1, 1979
Different gastric, pancreatic, and biliary responses to solid-liquid or homogenized mealsJ R Malagelada, V L Go, W H Summerskill
Gastroenterology|September 1, 1976
Responses to treatment can differentiate chronic active liver disease with cholangitic features from the primary biliary cirrhosis syndromeA P Geubel, A H Baggenstoss, W H Summerskill
Gastroenterology|October 1, 1979
Development and early prognosis of esophageal varices in severe chronic active liver disease (CALD) treated with prednisoneA J Czaja, A M Wolf, W H Summerskill
The Journal of Clinical Investigation|August 1, 1970
Pancreozymin bioassay in man based on pancreatic enzyme secretion: potency of specific amino acids and other digestive productsV L Go, A F Hofmann, W H Summerskill
Annals of Clinical Research|June 1, 1976
Failure of customary treatment in chronic active liver disease: causes and managementS W Schalm, H V Ammon, W H Summerskill
Mayo Clinic Proceedings|December 1, 1976
Development of radioimmunoassays for prednisone and prednisolone. Application to studies of hepatic metabolism of prednisoneS W Schalm, W H Summerskill, V L Go
Pageof 3